Immunohistochemical analysis on biological markers in ductal carcinoma in situ of the breast.

Autor: Iwase, Hirotaka, Ando, Yoshiaki, Ichihara, Shu, Toyoshima, Satoshi, Nakamura, Taka-aki, Karamatsu, Shoji, Ito, Yukashi, Yamashita, Hiroko, Toyama, Tatsuya, Omoto, Yoko, Fujii, Yoshitaka, Mitsuyama, Shoushu, Kobayashi, Shunzo
Zdroj: Breast Cancer (13406868); Apr2001, Vol. 8 Issue 2, p98-104, 7p
Abstrakt: The increasing use of mammographic screening has led to an increased detection of ductal carcinoma in situ (DCIS) of the breast. The detailed biological characteristics of DCIS and a new classification of DCIS based on these characteristics are needed. Immunohistochemical studies were performed to assess the expression of c-erbB-2 (ErbB-2), estrogen receptor (ER), p53 and proliferative activity (Ki-67) in 65 patients with pure DCIS and 60 with invasive ductal carcinoma (IDC). We classified pure DCIS tumors using three classifications, the architectural, Nottingham, and Van Nuys classifications. ErbB-2, ER and p53 staining was positive in 34%, 66% and 21% of patients with DCIS, respectively, and 58%, 42% and 33% in patients with IDC, respectively. Ki-67 stained positively in 1.5 % of patients with DCIS and 11.2 % of patients with IDC. The comedo type showed a high rate of positive ErbB-2 and p53 staining. The cribriform and papillary types showed a high rate of positive ER staining. Under the Van Nuys classification, ErbB-2, p53 and Ki-67 expression were highest in the group with high nuclear grade and lowest in the group with non-high nuclear grade without necrosis. Although the biological markers of IDC tended to suggest aggressive behavior more so than those of DCIS, these differences were based on the histological sub-type, comedo or non-comedo. The Van Nuys classification best defined the subgroups of DCIS with a distinct expression pattern of biological markers, and the best candidates for breast-conserving surgery. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index